Archives: Press Releases

MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of…

MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Third Quarter…

SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider…

MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results…

Collaboration Will Utilize PacBio’s Highly Accurate HiFi Sequencing to Solve Rare Pediatric Genetic Diseases That Have Proven Intractable in Previous Studies KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15,…

New System Features Advanced On-Instrument Data Processing and Cloud Enablement to Deliver HiFi Data Faster and With Significant Reduction in Compute and Data Storage Costs MENLO PARK, Calif., Oct. 05,…

MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the…

MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced…

MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of…

Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO MENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) —…

MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total revenue…

Joint Research Effort Will Lead to Molecular Assays That Can Improve Variant Detection and Access Difficult-to-Sequence Regions of the Human Genome AUSTIN, Texas and MENLO PARK, Calif., Aug. 03, 2020…

MENLO PARK, Calif., July 24, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results…

Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes, CFO to retire in August 2020 MENLO PARK, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of…

MENLO PARK, Calif., June 08, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the…